Ad5-nCoV Unknown Status Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Unknown Status | Prevention | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05303584 | Heterologous Boost Immunization With Ad5-nCoV After Three-dose Priming With an Inactivated SARS-CoV-2 Vaccine |